Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV003768909 | SCV004697390 | likely benign | RPE65-related recessive retinopathy | 2024-02-19 | reviewed by expert panel | curation | NM_000329.3(RPE65):c.496-4G>A is a non-coding variant near the junction of intron 5 with exon 6. This variant is present in gnomAD v.2.1.1 at a GrpMax allele frequency of 0.001437, with 59 alleles / 24910 total alleles in the African/African-American population, which is higher than the ClinGen LCA / eoRD VCEP BS1 threshold of >0.0008 (BS1). The splicing impact predictor SpliceAI gives a delta score of 0.01 for either acceptor loss or acceptor gain, which is below the ClinGen LCA / eoRD VCEP recommended threshold of <0.1 and does not predict an impact on splicing (BP4). In summary, this variant meets the criteria to be classified as likely benign for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA / eoRD VCEP: BS1, BP4. (VCEP specifications version 1.0.0; date of approval 09/21/2023). |
Invitae | RCV000945902 | SCV001091973 | likely benign | Leber congenital amaurosis 2; Retinitis pigmentosa 20 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001275285 | SCV001460285 | uncertain significance | Leber congenital amaurosis | 2020-04-30 | no assertion criteria provided | clinical testing |